These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [The Vogt-Koyanagi-Harada syndrome]. DENES ARDUINO E, HUBERMAN ED. Prensa Med Argent; 1961 Oct 13; 48():2797-9. PubMed ID: 13885411 [No Abstract] [Full Text] [Related]
43. [Vogt-Koyanagi-Harada syndrome: glucocorticoid therapy and visual prognosis]. Zhang M, Liu Q, Min H, Du H, Hu T. Zhonghua Yan Ke Za Zhi; 2002 Apr 13; 38(4):200-3. PubMed ID: 12133385 [Abstract] [Full Text] [Related]
45. [Some peculiarities of the Fogt-Kojanagy-Harada syndrome]. Shpak NI, Fedorova LI, Chuĭko RN. Oftalmol Zh; 1975 May 13; 30(7):546-8. PubMed ID: 1208016 [No Abstract] [Full Text] [Related]
46. [Choroiditis in multiple sclerosis and so-called uveoencephalomeningitis]. Bammer H, Hofmann A, Zick R. Dtsch Z Nervenheilkd; 1965 Jul 02; 187(3):300-16. PubMed ID: 5892328 [No Abstract] [Full Text] [Related]
47. Intrafamilial occurrence of tubulointerstitial nephritis with uveitis and Vogt-Koyanagi-Harada syndrome. Zaoutis LB, Rose CD, McKay CP. J Rheumatol; 1999 Nov 02; 26(11):2496-8. PubMed ID: 10555918 [Abstract] [Full Text] [Related]
48. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. Hirose S, Saito W, Yoshida K, Saito M, Dong Z, Namba K, Satoh H, Ohno S. Acta Ophthalmol; 2008 Dec 02; 86(8):902-7. PubMed ID: 19016661 [Abstract] [Full Text] [Related]
49. MRI documented acute myelitis in a patient with Vogt-Koyanagi-Harada syndrome: first report. Dahbour SS. Clin Neurol Neurosurg; 2009 Feb 02; 111(2):200-2. PubMed ID: 18980794 [Abstract] [Full Text] [Related]
50. Vogt-Koyanagi-Harada syndrome in a 10-year-old child. Ghosh AK, Bhaduri G, Deb A, Singh M, Das K. J Indian Med Assoc; 2007 Apr 02; 105(4):210, 212. PubMed ID: 17822191 [Abstract] [Full Text] [Related]
51. [The Vogt-Koyanagi-Harada syndrome: a rare differential diagnosis of uveitis in childhood. A case report taking into account the revised diagnostic criteria]. Rieger R, Keitzer R, Pleyer U. Klin Monbl Augenheilkd; 2005 Nov 02; 222(11):919-22. PubMed ID: 16308827 [Abstract] [Full Text] [Related]
52. Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome. Agarwal M, Ganesh SK, Biswas J. Ocul Immunol Inflamm; 2006 Dec 02; 14(6):333-9. PubMed ID: 17162603 [Abstract] [Full Text] [Related]
57. Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection. Papastathopoulos K, Bouzas E, Naoum G, Vergados I, Tsiodras S. J Infect; 2006 Feb 02; 52(2):e59-61. PubMed ID: 15951019 [Abstract] [Full Text] [Related]
59. Retinal pigment epithelium disorder in Vogt-Koyanagi-Harada disease revealed by hyperosmolarity response of ocular standing potential. Madachi-Yamamoto S, Kawasaki K, Yonemura D. Jpn J Ophthalmol; 1984 Jul 02; 28(4):362-9. PubMed ID: 6530837 [Abstract] [Full Text] [Related]
60. [Investigation of interferon in the sera and cerebrospinal fluid of patients with Vogt-Koyanagi-Harada disease (author's transl)]. Kato F, Ohno S, Matsuda H, Fujii N, Minagawa T. Nippon Ganka Gakkai Zasshi; 1981 Mar 02; 85(3):217-21. PubMed ID: 6168187 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]